Citation 1:
    Title: Johnson & Johnson beats profit estimates on strong Darzalex, medtech sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/johnson-johnson-beats-profit-estimates-strong-darzalex-medtech-sales-2025-07-16/#:~:text=Johnson%20%26%20Johnson%20surpassed%20second,to
    Location: chars 787–1004

Citation 2:
    Title: Johnson & Johnson beats profit estimates on strong Darzalex, medtech sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/johnson-johnson-beats-profit-estimates-strong-darzalex-medtech-sales-2025-07-16/#:~:text=Johnson%20%26%20Johnson%20surpassed%20second,to
    Location: chars 1165–1382

Citation 3:
    Title: J&J beats quarterly sales and profit estimates on cancer drug sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-beats-quarterly-sales-profit-estimates-cancer-drug-sales-2025-01-22/#:~:text=acquisition%20of%20Intra,67%20billion%20in%20sales
    Location: chars 1383–1594

Citation 4:
    Title: Johnson & Johnson beats profit estimates on strong Darzalex, medtech sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/johnson-johnson-beats-profit-estimates-strong-darzalex-medtech-sales-2025-07-16/#:~:text=billion%2C%20above%20the%20projected%20%2422,to%20%24200%20million%20from%20%24400
    Location: chars 1716–1968

Citation 5:
    Title: J&J earnings beat estimates on strong cancer drug sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-beats-wall-street-quarterly-sales-profit-estimates-cancer-drug-sales-2025-04-15/#:~:text=healthcare%20giant%20reported%20adjusted%20earnings,Cellular%2C%20although%20it%20maintained%20its
    Location: chars 1969–2240

Citation 6:
    Title: J&J beats quarterly sales and profit estimates on cancer drug sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-beats-quarterly-sales-profit-estimates-cancer-drug-sales-2025-01-22/#:~:text=acquisition%20of%20Intra,67%20billion%20in%20sales
    Location: chars 3937–4148

Citation 7:
    Title: Johnson & Johnson beats profit estimates on strong Darzalex, medtech sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/johnson-johnson-beats-profit-estimates-strong-darzalex-medtech-sales-2025-07-16/#:~:text=Johnson%20%26%20Johnson%20surpassed%20second,to
    Location: chars 4309–4526

Citation 8:
    Title: Cancer drug sales lift J&J past Wall Street expectations
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-lifts-profit-sales-forecasts-beats-wall-street-expectations-2024-10-15/#:~:text=cell%20therapy%20Carvykti%20achieved%20%24286,quarter%20adjusted
    Location: chars 4527–4755

Citation 9:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=In%202024%2C%20worldwide%20sales%20increased,changes%20consisted%20of%20the%20following
    Location: chars 4877–5072

Citation 10:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=Sales%20by%20U,5%C2%A0billion%20in
    Location: chars 5073–5215

Citation 11:
    Title: jnj-20241229
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm#:~:text=In%202024%2C%20worldwide%20sales%20increased,changes%20consisted%20of%20the%20following
    Location: chars 5278–5473

Citation 12:
    Title: J&J beats quarterly sales and profit estimates on cancer drug sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-beats-quarterly-sales-profit-estimates-cancer-drug-sales-2025-01-22/#:~:text=acquisition%20of%20Intra,67%20billion%20in%20sales
    Location: chars 6081–6292

Citation 13:
    Title: J&J sues Samsung Bioepis over contract breach for Stelara biosimilar
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-sues-samsung-bioepis-over-contract-breach-stelara-biosimilar-2025-02-24/#:~:text=Johnson%20%26%20Johnson%20,S
    Location: chars 6434–6627

Citation 14:
    Title: Johnson & Johnson beats profit estimates on strong Darzalex, medtech sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/johnson-johnson-beats-profit-estimates-strong-darzalex-medtech-sales-2025-07-16/#:~:text=billion%2C%20above%20the%20projected%20%2422,to%20%24200%20million%20from%20%24400
    Location: chars 7596–7848

Citation 15:
    Title: J&J beats quarterly sales and profit estimates on cancer drug sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-beats-quarterly-sales-profit-estimates-cancer-drug-sales-2025-01-22/#:~:text=acquisition%20of%20Intra,67%20billion%20in%20sales
    Location: chars 7849–8060

Citation 16:
    Title: J&J beats quarterly sales and profit estimates on cancer drug sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-beats-quarterly-sales-profit-estimates-cancer-drug-sales-2025-01-22/#:~:text=acquisition%20of%20Intra,67%20billion%20in%20sales
    Location: chars 8312–8523

Citation 17:
    Title: Johnson & Johnson beats profit estimates on strong Darzalex, medtech sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/johnson-johnson-beats-profit-estimates-strong-darzalex-medtech-sales-2025-07-16/#:~:text=%248,The%20company%20also%20raised
    Location: chars 8908–9112

Citation 18:
    Title: J&J sues Samsung Bioepis over contract breach for Stelara biosimilar
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-sues-samsung-bioepis-over-contract-breach-stelara-biosimilar-2025-02-24/#:~:text=unnamed%20private%20label%20provider,Pharmaceuticals%20and%20Alvotech%20launched%20Selarsdi
    Location: chars 9306–9562

Citation 19:
    Title: J&J hit with new class action over talc seeking medical monitoring for cancer
    URL: https://www.reuters.com/legal/jj-hit-with-new-class-action-over-talc-seeking-medical-monitoring-cancer-2024-06-18/#:~:text=Johnson%20%26%20Johnson%20is%20facing,of%20women%2C%20excluding%20the%2061%2C000
    Location: chars 9840–10064

Citation 20:
    Title: Cancer drug sales lift J&J past Wall Street expectations
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-lifts-profit-sales-forecasts-beats-wall-street-expectations-2024-10-15/#:~:text=cell%20therapy%20Carvykti%20achieved%20%24286,quarter%20adjusted
    Location: chars 10241–10469

Citation 21:
    Title: J&J beats quarterly sales and profit estimates on cancer drug sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-beats-quarterly-sales-profit-estimates-cancer-drug-sales-2025-01-22/#:~:text=acquisition%20of%20Intra,67%20billion%20in%20sales
    Location: chars 10874–11085

Citation 22:
    Title: J&J sues Samsung Bioepis over contract breach for Stelara biosimilar
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-sues-samsung-bioepis-over-contract-breach-stelara-biosimilar-2025-02-24/#:~:text=unnamed%20private%20label%20provider,S
    Location: chars 11516–11719

Citation 23:
    Title: J&J hit with new class action over talc seeking medical monitoring for cancer
    URL: https://www.reuters.com/legal/jj-hit-with-new-class-action-over-talc-seeking-medical-monitoring-cancer-2024-06-18/#:~:text=Johnson%20%26%20Johnson%20is%20facing,of%20women%2C%20excluding%20the%2061%2C000
    Location: chars 13726–13950

Citation 24:
    Title: J&J sues Samsung Bioepis over contract breach for Stelara biosimilar
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-sues-samsung-bioepis-over-contract-breach-stelara-biosimilar-2025-02-24/#:~:text=unnamed%20private%20label%20provider,S
    Location: chars 13951–14154

Citation 25:
    Title: jnj-20231231
    URL: https://www.sec.gov/Archives/edgar/data/200406/000020040624000013/jnj-20231231.htm#:~:text=Net%20cash%20flows%20from%20operating,711
    Location: chars 14878–15027

Citation 26:
    Title: J&J beats quarterly sales and profit estimates on cancer drug sales
    URL: https://www.reuters.com/business/healthcare-pharmaceuticals/jj-beats-quarterly-sales-profit-estimates-cancer-drug-sales-2025-01-22/#:~:text=acquisition%20of%20Intra,67%20billion%20in%20sales
    Location: chars 15545–15756

Citation 27:
    Title: J&J hit with new class action over talc seeking medical monitoring for cancer
    URL: https://www.reuters.com/legal/jj-hit-with-new-class-action-over-talc-seeking-medical-monitoring-cancer-2024-06-18/#:~:text=Johnson%20%26%20Johnson%20is%20facing,of%20women%2C%20excluding%20the%2061%2C000
    Location: chars 17318–17542

